Loading...

CNTB CONNECT BIOPHARMA HOLDINGS LTD Capital Structure Changes 8-K Filing

CNNC

CNTB

CONNECT BIOPHARMA HOLDINGS LTD

(CNTB)

2025 8-K

Financial Results Released

Share Placement Funding

Board Resignation

Financial Results Announced

Insider Share Purchases

Financial Results Released

Equity Offerings

New Drug Application

Financial Statements

Market Expansion

Product Expansion

FDA Meeting Update

Financial Results

Nasdaq Compliance Notice

Management Changes

Management Changes

Financial Results Update

Management Changes

Management Changes

Financial Results Announcement

Board Appointment

External Links:

On July 18, 2025, Connect Biopharma Holdings Ltd announced it is terminating its Deposit Agreement for American Depositary Shares (ADSs), with the ADR program set to end around September 2, 2025, and plans for a direct listing of Ordinary Shares on Nasdaq under the symbol 'CNTB'. This change will facilitate a one-for-one exchange of ADSs for Ordinary Shares for shareholders.

AI Assistant

CONNECT BIOPHARMA HOLDINGS LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.